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Abstract
Parietal chest wall tuberculosis is an extremely rare manifestation of tuberculosis (TB) in children. We present the
case of a 15 month-old girl presenting with a chest wall lesion initially thought to be of neoplastic origin and
eventually diagnosed as chest wall TB, which was treated with surgical debridement and specific antitubercular
therapy. The girl had not-measurable 25-hidroxy-vitamin D levels, an increasingly recognized risk factor for the
development of active TB. To our knowledge, in the English literature there are no similar described cases in such
young infants. This case highlight the possibility of dealing with TB and its different manifestations also in low TB
burden countries, due to continuously increasing migration flows. A detailed history is a key point to reach the
diagnosis. Moreover, our case confirm the possible non casual relationship between TB and low 25-hidroxy-vitamin
D levels, pointing out the importance of measuring its levels in all TB patients and considering its supplementation
in addition to specific antitubercular therapy.
Background
Tuberculosis (TB) of bones and joints accounts for
about 10% of all extrapulmonary TB infections [1,2]. In
developing countries, 1-5% of children less than 10
years of age with untreated primary infection due to
Mycobacterium tuberculosis (Mtb) develop osteoarticular
TB [1,3]. The spine is the most frequently affected site
(40-60%), followed by methapyses of long bones, upper
extremity bones and non-weight-bearing bones [3]. The
infection reaches bones through a lymphohematogenous
route, although direct spread from infected lymph nodes
may occur [4]. Parietal chest wall TB is rare and rib TB
is even rarer [5,6], constituting 1-3% of bone and joint
TB [7].
Chest wall TB needs to be differentiate from benign
and malignant tumors (chondroma, osteochondroma,
fibrous dysplasia, lipoid granuloma, chondrosarcoma,
myeloma multiplex) [8], metastatic carcinoma, lym-
phoma or other kinds of infection [9-12].
The diagnosis of chest wall TB is often delayed due to
lack of specific symptoms and signs and an indolent
course [13] and less than 50% of patients have a
concomitant active pulmonary TB [8,14]. Radiologic
findings vary depending on the stage at presentation
[1,3]. Acid fast bacilli (AFB) and cultures of bone are
positive in up to 75% of cases, and histopathology is
often diagnostic [8].
The treatment of choice of chest wall TB is still
debated, nevertheless the majority of described cases
have been treated with surgical debridement (or excision
based on lesion extension) and antitubercular therapy.
Epidemiological and in vitro studies have found increas-
ing evidences about a link between active TB and low
25-hidroxy-vitamin D (25-OH-D) levels, 25-OH-D repla-
cement has been recently proposed as adjunctive ther-
apy for TB treatment [15,16]. Nevertheless, the potential
benefits of vitamin D as adjunctive therapy in mycobac-
terial infections are uncertain [17,18].
We present the case of a 15 month-old girl, with not-
measurable 25-hidroxy-vitamin D (25-OH-D) levels, pre-
senting with a chest wall lesion initially thought to be of
neoplastic origin eventually diagnosed as chest wall TB,
treated with surgical debridement and specific antituber-
cular therapy. At one year follow-up no disease recur-
rence have been reported. To our knowledge, in the
English literature there are no similar described cases in
such young infants. * Correspondence: danilobuonsenso@gmail.com
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A 15 month-old girl was referred to the emergency
room of our institution because of the appearance of a
progressively increasing right painless parasternal
swelling.
The girl had been admitted 2 weeks before in a hospi-
tal in Romania where chest wall ultrasonography (US),
chest X-ray and chest computed tomography (CT) scan
had been performed (Figure 1a, b). The US study
revealed a well circumscribed, 25 mm per 9 mm in size,
hypoechoic collection adherent to the cartilagean rib.
Chest x-ray showed enlargement of hilar lymph nodes
and right lung consolidation. Chest CT scan showed
parenchymal consolidation with area of calcification in
the right lower lobe, bilateral area of atelectasis, med-
iastinal and hilar lymph node enlargement, a patchy
hypoechoic mass adjacent to the 10
th right cartilagean
rib. Because of the association of chest wall swelling and
lung lesion, a tumor was suspected and a bone marrow
aspirate was performed, which ruled out neoplastic infil-
tration. A surgical management of both bone and par-
enchymal lesions was proposed by doctors, but parents
refused and sought care at our hospital.
On examination at our institution, the child had no
fever, presented a cold, bluish, painless, right parasternal
swelling (Figure 2). The physical examination was other-
wise normal.
A detailed medical history was taken. The child had
had two episodes of pneumonia when was 5 and 7
month-old, which were treated and cured with antibio-
tics and steroids. Family history was negative for neo-
plastic disease, but was positive for three cases of active
TB. The child did not receive bacillus Calmette-Guérin
vaccine at birth because it was not available. A new
chest wall US study (Figure 1c) showed a well circum-
scribed, 25 mm per 12 mm in size, hypoechoic collec-
tion with peripheral area of hypervascularization
adjacent to the cartilagean rib. The child was admitted
at the Pediatric Infectious Disease Unit of our hospital.
Investigations revealed normal hemogram, liver and
renal function tests, blood sugar and urinalysis, low levels
of serum 25-OH-D (< 7 ng/ml) with normal calcium,
phosphorus, PTH and alkaline phosphatasis level, normal
serum protein electrophoresis, negative serology for
human immunodeficiency virus. QuantiFERON TB Gold
In Tube test (QTF) resulted positive (> 10 IU/l) and
Figure 1 a: chest x-Ray showing right lung hypodiaphany; b: Computed Tomography scan performed during the first hospitalization
in Romania showing a ring-enhanced, well-circumscribed abscess adherent to the cartilagean rib; c: ultrasonography study performed
at our institution, showing a lesion with peripheral area of hypervascularization.
Buonsenso et al. Italian Journal of Pediatrics 2012, 38:12
http://www.ijponline.net/content/38/1/12
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48 hours. Even though the use of QTF test in children is
still unclear, we performed it since we are currently per-
forming a correlation study between QTF and TST in chil-
dren; nevertheless, in our case QTF result was only one of
a number of elements (history, clinical and radiologic find-
ings and TST result) which let us suspect a TB aetiology.
Early morning gastric aspirates performed on three conse-
cutive days were negative for acid-fast bacilli, but both
Polymerase Chain Reaction (PCR) and culture for Mtb
were positive. A surgical debridement of the lesion was
performed. Hystopathologic studies revealed a predomi-
nantly lymphomononuclear infiltrate with epithelioid cells
and Langhans giant cells (Figure 3). PCR and culture for
Mtb were positive on pus and tissue smears. A diagnosis
of chest wall and pulmonary TB was performed, antituber-
culous therapy (isoniazid, rifampin and pyrazinamide) was
started and vitamin D was replaced with ergocalciferol
Figure 2 a, b. The patient’ lesion.
Figure 3 a, b, c. Hystopathologic findings of the chest wall lesion showing typical findings of a tuberculosis infected tissue.
Hematoxylin- and eosin-stained sections. a: bands of epithelioid histiocytes (palisading arrangement); b: Langhans giant cells; c: discrete
granulomas; d: caseation necrosis (acellular pink areas of necrosis with karyorrhectic debris). Kind concession of Vellone VG, Department of
Pathology, Policlinico Gemelli, Catholic University, Rome, Italy.
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patient had no adverse drug reactions and experienced no
disease recurrence (based on clinical evaluation with
detailed auxological evaluation and chest x-Ray studies -
preferred to CT studies because of lower radiation burden,
which showed resolution of pulmonary involvement and
only a residual scar related to the surgery) at one year fol-
low-up.
Discussion
Tubercular parietal chest wall abscess is a rare form of
extrapulmonary TB [19]. In a study, chest wall TB
accounted for 1-5% of all cases of bone and joint TB
[5]. Rib TB is rarely observed, occurring in 1-3% of all
cases of bone and joint TB [12]. In Tatelman’ss e r i e s
[20] rib TB was observed in 5% of all cases of bone and
joint TB, and only in 0.1% of all hospital admissions for
TB over a 10 year-period.
This rare localization of TB is more common in high
TB burden countries and the majority of cases occur in
children and young adults (range 4-76 years, mean age
25-30 years) [8].
TB rib lesions usually involve the midshaft of rib or the
parasternal area [21]. The most frequent site of involve-
ment described by Tatelman and Drouillard [20] was the
rib shaft (61%), followed by the costovertebral joint (35%)
and costochondral junction (13%). However, Johnson and
Rothstein [22] and Lee et al. [23] found the costochon-
dral junction to be the most frequent site of involvement.
In agreement with the literature, our patient’sl e s i o nw a s
adherent to the costochondral joint.
Associated pleuropulmonary TB, which was present in
our case, has been reported in about 30 to 40% of cases
[24].
Chest wall TB is believed to be attributed mainly to
hematogenous dissemination, as we think it happened in
our patient. Nevertheless, the presence of an underlying
contiguous tuberculous mediastinitis, a lung cavity or a
chest wall lymphadenitis can suggest local extension to
the rib [25].
As with any diagnostic problem, careful evaluation of
the clinical history and physical findings, together with
any specific laboratory tests, may contribute consider-
ably to the differential diagnosis.
The history of TB infection in the past or close con-
tact with people with active TB is helpful to suggest the
possibility of TB, though it is not always present. In this
case, the patient had a family history of three close rela-
t i v e sw i t ha c t i v eT B ,ad a t at h a ts h o u l da l w a y sl e tt h e
physician to include TB in the differential diagnosis.
Interestingly, TB was not considered in this case even in
a high TB burden country like Romania.
Prolonged period of the presence of a swelling, cold
abscess formation (the absence of which makes the
diagnosis difficult [26]) and non-healing sinus are the
common presentation.
In addition to history and a good clinical examination,
use of radiologic studies (chest X-Ray, US and CT scan
which can help demonstrate the skeletal lesion and any
associated abscess or lung involvement [23]), bone scin-
tigram, histologic and bacteriologic examination (using
PCR which increases the diagnostic yield) of the opera-
tive specimen obtained by biopsy (whether open or CT
guided, biopsy remains the gold standard for the diagno-
sis) are necessary steps to achieve a definitive diagnosis
[5,27-29].
The differential diagnosis of chest wall lesions is wide
and comprises mainly benign and malignant tumors and
infections (table 1). Among the infective rib lesions,
mycobacterial and bacterial infections are seen with
equal frequency, followed by fungal ostemyelitis [30].
Apart from Mtb, bacterial infections caused by Staphylo-
cocci, Streptococci, Salmonella, Haemophilus influenzae,
Brucella and Actinomycetes, and fungi infections such as
coccidioidomycosis and blastomycosis can also cause rib
osteomyelitis [30]. The benign tumors involving rib are
chondroma (commonest), osteochondroma, fibrous dys-
plasia, and lipoid granuloma while the malignant lesions
are chondrosarcoma, myeloma multiplex and secondary
deposits from the lung and breast. All these present as
expansion of the rib at the affected site, lytic lesion or
pathological fractures [8]. In general, TB is the second
most common cause of destructive rib lesions after
metastatic neoplasms.
In our case, the origin in a high TB burden country
and the presence of close relatives with active TB in the
family, made us suspect about a possible lung TB with
dissemination to the chest wall. Our suspicion was con-
firmed by a positive TST and Quantiferon TB-Gold in
tube test, and by gastric washing microbiologic results.
Once the diagnosis of lung TB was confirmed, we
decided to manage surgically the chest wall lesion,
which allowed us to have histopathological and micro-
biological confirmation of the TB atiology. Nevertheless,
the best management of chest wall TB is still debated. A
study of four cases stated that surgery is rarely indicated
and antitubercular therapy is sufficient once the diagno-
sis is established by histology [5]. In another large series
of 712 cases, spanning 11 years, surgical treatment was
advocated for parietal chest wall TB [31]. Chen et al.
also suggested that surgical debridement is necessary in
treating TB of ribs followed by antitubercular therapy
for six months [32]. Agrawal et al. recently described
their experience with 7 patients (aged 4 to 18 years)
with chest wall TB, which were all managed with sur-
gery (either resection or curettage of the abscess cavity
and extraction of the infected granulation tissue) fol-
lowed by one-year antitubercular therapy. No relapses
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agreement with Agrawal and Chen experiences, we also
support surgical management (either resection or curet-
tage, based on operative findings) as it ensures the
removal of the diseased area, enables histopathological
confirmation, enhances post-surgical neovascularization
in the healing tissues which aids in better distribution of
the antitubercular drugs, thereby increasing the efficacy
and ultimate response to therapy [8].
We chose a three drug regimen for our patient instead
of using 4 drugs for the first 2 months of treatment,
since a three drug regimen has a proven 99% cure rate
[33]; quadruple therapy with the addition of ethambutol
or streptomycin in the intensive phase is generally
recommended where there is high risk of isoniazid-drug
resistance [33], which we considered was not the case
for our patient. The good treatment response of our
patient and no relapse at one year follow-up prove that
the chosen treatment was adequate for this case.
Our patient had non measurable levels of 25-OH-D.
The Endocrine Society’s clinical practice guidelines
define vitamin D deficiency as 25-OH-D < 20 ng/ml (50
nmol/l) and vitamin D insufficiency as 25-OH-D levels
of 21-29 ng/ml (52.5-72.5 nmol/l) [34]. This aspect is of
particular interest due to recent findings on the role of
25-OH- D in the modulation of the immune response
and the epidemiological correlation between low 25-
OH- D levels and TB.
In fact, clinical outcome of TB depends primarily on
cell-mediated innate and acquired immune responses,
where macrophages and T lymphocytes play an essential
role. The first step of infection after transmission of
Mtb into the lower respiratory tract involves the activa-
tion of macrophages, the primary host cells for myco-
bacteria, via toll-like receptors. Toll-like receptor-
mediated activation of human macrophages by Mtb
upregulates expression of the genes encoding VDR and
vitamin-D-1-hydroxylase (CP27B), the enzyme that con-
verts 25-hydroxycholecalciferol (25OHD) to calcitriol
(1,25(OH)2D). This leads to a vitamin D-dependent pro-
duction of LL-37, an antimicrobial peptide of the cathe-
licidin family, within macrophages and increased
macrophage-dependent killing of mycobacteria. Addi-
tionally, cathelicidin modulates the immune response to
Mtb by attracting peripheral blood neutrophils, mono-
cytes, and T cells [17,35].
An association between TB and vitamin D deficiency
is suggested by numerous observational studies. A meta-
analysis examined 3 prospective studies and 4 case-con-
trol studies published between 1980 and 2006 and
found a medium-to-strong association between low
serum values and the risk of active TB in humans [15].
In addition, Martineau et al. [16] discover a striking
temporal relationship between vitamin D deficiency and
TB. The reporting of new TB cases in Cape Town,
South Africa, was lowest in the months after the seaso-
nal increase in serum 25-OH-D levels, whereas the
reporting of new TB cases was highest in the months
following the season with the lowest serum 25-OH-D
levels [36]. Nevertheless, the potential benefits of vita-
min D as adjunctive therapy in mycobacterial infections
are uncertain. A randomized, double-blind, placebo-con-
trolled trial in a large cohort of TB contacts in London
indicated that a single dose of 2.5 mg vitamin D had an
interferon-g independent growth restrictive effect on
mycobacteria [37]. A systematic review concluded that
evidence do not clearly support the use of 25-OH-D in
the treatment of TB but supports further research into
its use as adjunctive TB therapy [17,18].
In conclusion, our report describes a rare TB localiza-
tion in a very young children, the youngest described in
the English literature. This case highlight the possibility
of dealing with TB and its different manifestations also in
low TB burden countries, due to continuously increasing
migration flows. A detailed history is a key point to reach
the diagnosis. Moreover, our case confirm the possible
non casual relationship between TB and low 25-OH-D
levels, pointing out the importance of performing clinical
trials aimed to better understand the role of 25-OH-D in
TB pathogenesis and its use in addition to specific antitu-
bercular therapy for the treatment of TB.
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